“Cancer and neurodegenerative diseases Positron Emission Tomography: is there a connection?”

Madrid, February 2010.- (PET) Positron Emission Tomography has become one of the most significant advances of the úlast 30 years in the diagnosis of cancer through molecular imaging. Now, it is beginning to yield results in the field of early diagnosis and monitoring of neurodegenerative diseases.

Jorge Barrio, Professor at the University of UCLA, United States, is one of the world’s leading researchers in the field of molecular image in relation to neurodegenerative diseases and positron emission tomography. Invited by the PET technological Institute, 18 February at 13: 00, explained in the bottle Prof. Hall of the Faculty of Medicine of the UCM, their latest research results and State of the issue at the international level.

Jorge Barrio is Professor of Molecular and Medical Pharmacology at UCLA and 40 years researching in the area of tomography positron emission. He currently devotes much of his effort to use the PET technique and the radiotracer in early diagnosis of neurodegenerative diseases such as malaria Alzheirmer.

Neighborhood is also member of the Board of the Academy of Molecular Imaging and editor of the journal Molecular Imaging and Biology. He has participated in the Nobel Conference on Molecular Imaging, in Stockholm in 2007; and has been published in the most prestigious scientific journals in the world, such as New England J. Med or the Proceedings of the National Academy of Sciences, U.S.A.